摘要
1新型抗结核药物研发的意义。1.1抗结核药物研发的必要性和紧迫性:至少有下面5条理由说明新型抗结核药物研究的必要性和紧迫性:
出处
《结核病与胸部肿瘤》
2005年第3期160-165,共6页
Tuberculosis and Thoracic Tumor
参考文献10
-
1Scientific blueprint for TB drug development, the Global Alliance for TB Drug Development forum. 2001,1-52.
-
2Andries K, Verhasseh P, Guilemont J, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science, 2005, 307(5707):223-227.Epub 2004 Dec 9.
-
3Igarashi M, Nakagawa N, Hattori S, et al. Caprazamycin A-F, novel anti-TB antibiotics from Streptomyces sp. (C)Abstr.42nd ICAAC,ASM.Washington,DC. Sept.2002:p.232.
-
4Stover CK, Warrener P, VanDevanter DR, et al. A small molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature,2000,405(6789): 962-969.
-
5McCune RM, Tompsett R ,McDermott. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. J.Exp.Med,1956,104:763-801.
-
6Cole ST. Comparative mycobactefial genomics as a tool for drug target and antigen discovery. Eur Respir J, 2000,20Suppl.36:78s-86s.
-
7MeKinney JD. In vivo veritas: the search for TB drug targets goes live. Nature Medieine,2000,6(12):1330-1333.
-
8Segal W, Bloch H. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J Bcteriol,1956, 72:132-141.
-
9Berthet FX. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science,1998,282:759-762.
-
10Glickman MS, Cox JS,Jocob WR Jr. A novel mycolic acid cycloprapane synthetase is required for ceding,persistence,and vindence of Mycobacterium tuberculosis. Mol Cell,2000,5:717-727.
同被引文献33
-
1孙冰梅,车志宏.结核分枝杆菌耐药的分子机制及耐药基因检测方法的研究进展[J].山西医药杂志,2005,34(4):301-303. 被引量:13
-
2江山,朱道银,骆旭东,蒋英,陈全.结核分枝杆菌DNA疫苗对小鼠结核病免疫治疗作用的实验研究[J].中华结核和呼吸杂志,2005,28(5):305-309. 被引量:18
-
3刘伟,司书毅,肖春玲.新型抗结核药物的研究进展[J].国外医药(抗生素分册),2006,27(2):91-95. 被引量:8
-
4吴雪琼,郑越,徐燕杰,张俊仙,陆阳,张灵霞,史迎昌,李洪敏,韩永,曹立雪,李忠明.不同剂量结核病DNA疫苗及细胞因子联合免疫的研究[J].中国免疫学杂志,2006,22(10):883-888. 被引量:5
-
5AMIT N,RAHUL J. Recent advances in new structural classes of anti-tuberculosis agents[ J]. Cult Med Chem,2005 ,12(16) :1873 - 1886.
-
6ANDRIES K, JOZEF L, MARCEL K, et al. Quinoline derivatives for the treatment of latent tuberculosis: WO ,2006/7048 A1 [ P]. 2006 - 06 - 29.
-
7JANIN Y L. Antituberculosis drugs: ten years of research [ J ]. Bioorg Med Chem, 2007, 15 ( 7 ) : 2479 - 2513.
-
8TSUBOUCHI H, SASAKI H, HARAGUCHI Y, et al. Antituberculous activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo [ 2,1 -b ] oxazoles [ J ]. Antirnicrob Agents Chemother, 2005,49 (1) :16- 19.
-
9WANG J H,ELCHERT B ,HUI Y,et al. Synthesis of trehalose-based compounds and their inhi-bitory activities against Mycobacterium smegmatis [ J]. Bioorg Med Chem,2004,12(24) :6397 -6413.
-
10AHMED K K, SRINIVASA R S, KALEEM A M, et al. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity [ J ]. Bioorg Med Chem,2006,14 (3) :650 - 658.
二级引证文献11
-
1韦莉,金齐力,刘勇,夏佩莹.结核分枝杆菌19 kDa脂蛋白诱导THP-1细胞凋亡的研究[J].蚌埠医学院学报,2008,33(3):263-265. 被引量:2
-
2王秀霞,王子玲.含莫西沙星方案治疗复治肺结核的临床疗效观察[J].中国当代医药,2009,16(8):58-60. 被引量:4
-
3王秀霞.益肺止咳胶囊辅助治疗耐药肺结核的临床评价[J].中国当代医药,2009,16(17):25-27. 被引量:6
-
4杨彩霞,杜文元.新喹诺酮类药物在治疗结核病中的应用[J].疾病监测与控制,2010,4(6):333-334. 被引量:1
-
5周则琼.皮肤型结核治疗的研究进展[J].临床肺科杂志,2011,16(1):93-94. 被引量:4
-
6张向东,张婷,牛建军,温慧欣,胡思玉,李庆阁.探针熔解分析法快速检测结核分枝杆菌链霉素耐药突变[J].中国人兽共患病学报,2011,27(1):53-57. 被引量:4
-
7陈春辉.探针熔解分析法快速检测结核分枝杆菌链霉素耐药突变[J].中国医药指南,2012,10(14):88-89. 被引量:2
-
8徐高宏.求函数定义域问题解析[J].数理化学习(高中版),2000(9):8-9.
-
9邹品娇,吴娟,姜云平,金伟华,蒋燕,于波涛,范开华.结核患者胸水中异烟肼浓度的测定[J].华西医学,2014,29(8):1483-1486. 被引量:2
-
10韩志娟,郑玉兰.含莫西沙星方案治疗复治肺结核的临床疗效观察[J].河南中医,2014,34(B06):66-67.
-
1张宗德,马玙.新型抗结核药物筛选的分子靶位研究进展[J].中国防痨杂志,2007,29(1):81-84. 被引量:4
-
2钱起龙,徐冬梅,李金娟,袁媛.左氧氟沙星治疗复治肺结核疗效观察[J].临床肺科杂志,2009,14(6):808-808.
-
3毕经瑞,邱兴屹.左氧氟沙星治疗复治肺结核疗效观察[J].吉林医学,2003,24(4):351-352. 被引量:7
-
4孙凯华.自拟方剂配合西药联合治疗难治性肺结核临床观察[J].中国中医药咨讯,2010(3):114-114.
-
5张继东,田义江.难治性肺结核208例治疗分析[J].实用医技杂志,2004,11(11B):2435-2435.
-
6陈玩玉.联合用药对难治性肺结核治疗分析[J].国际医药卫生导报,2006,12(4):79-80. 被引量:3
-
7罗飞.左氧氟沙星联合抗结核药治疗结核性胸腔积液21例疗效观察[J].医学文选,2003,22(3):359-360.
-
8林涛,王优,林爱俊.左氧氟沙星方案治疗结核性胸腔积液29例疗效观察[J].中国防痨杂志,2001,23(5):328-329. 被引量:2
-
9王强,张成刚,李大魁.伊马替尼用于慢性粒细胞性白血病治疗的药物经济学评价[J].中国药学杂志,2005,40(6):472-474. 被引量:9
-
10刘晓辉.抗动脉粥样硬化的新靶位─高密度脂蛋白受体SR-BI[J].国外医药(抗生素分册),2003,24(2):70-73. 被引量:6